Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages | Life Science Alliance
Activation of pancreatic stellate cells involves an EMT-like process
Median overall survival according to CA 19-9 serum level baseline level. | Download Scientific Diagram
Clinical and laboratory diagnosis of chronic pancreatitis | Pancreapedia
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Deciphering Pancreatic Islet β Cell and α Cell Maturation Pathways and Characteristic Features at the Single-Cell Level - ScienceDirect
Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect
Possible Diagnostic Marker for Pancreatic Cancer - NCI
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Tests for Pancreatic Cancer Diagnosis | CTCA | City of Hope
Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer - Dong - 2018 - Cancer Science - Wiley Online Library
Pancreatic cancer | Mosaiques Diagnostics And Therapeutics AG
Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma | Scientific Reports
Pancreatic cyst fluid levels of amylase and tumour markers | Download Table
CA19-9 Levels in Saliva and Urine of Patients with Ductal Adenocarcinoma of the Pancreas Correlates with Serum CA19-9 Levels - A Prospective Preliminary Study
Pancreatic cyst fluid levels of amylase and tumor markers | Download Table
![PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f7bb4eb6de25f6ecb9323cbef8061896f020a0da/2-Table1-1.png "PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar")
PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar
Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin | PLOS ONE
Tumor markers in pancreatic cancer: 2013. | Semantic Scholar
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine
Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer | British Journal of Cancer
IJMS | Free Full-Text | Multifactorial Scores and Biomarkers of Prognosis of Acute Pancreatitis: Applications to Research and Practice
antic Nedreptate peren marker cancer pancreatic satelit În zori împrejmuire
Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy
